(Q52197218)

26 April 2018

title

MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice. (English)

1 reference

26 April 2018

1 reference

Kim HS

1

1 reference

26 April 2018

Jang CG

series ordinal

2

1 reference

26 April 2018

publication date

1 January 1997

1 reference

26 April 2018

published in

Brain Research Bulletin

1 reference

26 April 2018

volume

44

1 reference

26 April 2018

issue

3

1 reference

26 April 2018

page(s)

221-227

1 reference

26 April 2018

SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Further evidence for a motility substitution test as a tool to detect the narcotic character of new drugs in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

The development of behavioral sensitization to apomorphine is blocked by MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

beta-Phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Blockade by ginseng total saponin of the development of methamphetamine reverse tolerance and dopamine receptor supersensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Cellular and molecular mechanisms of drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Characteristics of the ambulation-increasing effect of the noncompetitive NMDA antagonist MK-801 in mice: assessment by the coadministration with central-acting drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Circadian variation in methamphetamine- and apomorphine-induced increase in ambulatory activity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Drug reinforcement studied by the use of place conditioning in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Molecular mechanisms of drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

In vivo demonstration of the enhancement of MK-801 by L-glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Dose-dependent conditioned place preference produced by etonitazene and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Dopaminergic substrates of amphetamine-induced place preference conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Methylxanthines (caffeine and theophylline) blocked methamphetamine-induced conditioned place preference in mice but enhanced that induced by cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Brain dopamine and reward

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2897%2900093-2

7 January 2021

10.1016/S0361-9230(97)00093-2

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9323434

1 reference

26 April 2018